BioMarin Pharmaceutical

BMRN | NASDAQ | 2 Obserwujący

$58.27

+1.02%

$0.59

Obserwuj

Overview Metrics Financials

Fair Price

$95.08

Undervalued by 18.4%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

BioMarin Pharmaceutical Inc. (BMRN) is an American biopharmaceutical company specializing in the research, development, and manufacturing of drugs for rare genetic diseases and rare disorders. With a broad portfolio of medicines serving the needs of patients with genetically determined disorders, BioMarin is a leading innovator in the treatment of genetic diseases. The company is known for its pioneering therapeutic approaches and longstanding commitment to patients with rare diseases. BioMarin also actively invests in the research and development of new drugs and therapies to improve the quality of life for patients. BioMarin Pharmaceutical Inc. (BMRN) shares could be suitable for investors looking to invest in the biopharmaceutical sector with a focus on treating rare genetic diseases and innovative research and development.

Feed

There are no posts to show right now.

BioMarin Pharmaceutical

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?